Statera Biopharma Inc (NASDAQ:STAB)

Delayed Data
As of Nov 26
 -0.22 / -6.25%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Statera Biopharma Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,112.12% increase from the last price of 3.30.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Statera Biopharma Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually -106.01%


Growthquarterly --
Growthannually 98.55%
Key to the earnings and sales forecast charts.